scholarly article | Q13442814 |
P50 | author | Melvin H Seid | Q88026358 |
P2093 | author name string | Ashwin Chatwani | |
Angelia D Butcher | |||
P2860 | cites work | A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia | Q38314781 |
How we diagnose and treat iron deficiency anemia | Q38593099 | ||
The safety of intravenous iron dextran in hemodialysis patients | Q40926289 | ||
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial | Q43291667 | ||
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. | Q45911764 | ||
Update on adverse drug events associated with parenteral iron | Q46212164 | ||
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia | Q46782839 | ||
High prevalence of postpartum anemia among low-income women in the United States | Q74415587 | ||
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial | Q80710282 | ||
Treatment for women with postpartum iron deficiency anaemia | Q24187876 | ||
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis | Q26822051 | ||
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial | Q34014222 | ||
Iron deficiency anemia in women across the life span | Q34315499 | ||
Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose | Q34700903 | ||
Safety in iron management | Q35140921 | ||
Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity | Q35141918 | ||
FGF-23: More than a regulator of renal phosphate handling? | Q35156017 | ||
Iron Deficiency and Erythropoiesis: New Diagnostic Approaches | Q35538677 | ||
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials | Q36241297 | ||
Management of Iron Deficiency Anemia | Q36812538 | ||
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia | Q37465214 | ||
A systematic analysis of global anemia burden from 1990 to 2010. | Q37535215 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 9642027 | |
P577 | publication date | 2017-04-13 | |
P1433 | published in | Anemia | Q26842521 |
P1476 | title | Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia | |
P478 | volume | 2017 |
Q90435077 | Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study |
Q88035892 | Ferric Carboxymaltose: A Review in Iron Deficiency |
Q92060061 | Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review |